长链非编码小核仁RNA宿主基因(lncRNA SNHG)在肝细胞癌发生发展中的作用

李雨韩; 郭北辰; 周凤; 韩涛

doi:10.3969/j.issn.1001-5256.2023.08.032

长链非编码小核仁RNA宿主基因(lncRNA SNHG)在肝细胞癌发生发展中的作用

DOI: 10.3969/j.issn.1001-5256.2023.08.032

李雨韩¹,
郭北辰¹,
周凤¹,
韩涛^{1, 2, , ,}

1.
天津医科大学人民临床学院消化(肝病)科，天津 300121
2.
南开大学人民医院消化(肝病)科，天津 300121

基金项目:

天津市自然科学基金 (19JCZDJC36700)

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：李雨韩撰写论文；郭北辰、周凤负责查阅及分析文献；韩涛负责指导文章撰写。

详细信息

通信作者:
韩涛，hantaomd@126.com (ORCID: 0000-0003-4216-6968)

计量
- 文章访问数: 362
- HTML全文浏览量: 144
- PDF下载量: 37
- 被引次数: 0
出版历程
- 收稿日期: 2022-11-08
- 录用日期: 2023-02-20
- 出版日期: 2023-08-20

Research advances in long non-coding small nucleolar RNA host gene in hepatocellular carcinoma

Yuhan LI¹,
Beichen GUO¹,
Feng ZHOU¹,
Tao HAN^{1, 2
, ,
,}

1.
Department of Gastroenterology and Hepatology, Clinical Medical College of Tianjin Medical University, Tianjin 300121, China
2.
Department of Gastroenterology and Hepatology, Tianjin Union Medical Center, Nankai University, Tianjin 300121, China

Research funding:

The Natural Science Foundation of Tianjin (19JCZDJC36700)

More Information

Corresponding author: HAN Tao, hantaomd@126.com (ORCID: 0000-0003-4216-6968)

摘要

摘要: 肝细胞癌(HCC) 是原发性肝癌中最常见的类型，也是癌症相关死亡的主要原因之一。尽管目前对HCC的研究逐渐深入，但其潜在的分子机制仍不清楚。近年来研究发现，长链非编码RNA (lncRNA) 在HCC的发生和发展中起着重要作用，而长链非编码小核仁RNA宿主基因(lncRNA SNHG) 在HCC中异常表达并在肿瘤细胞的增殖、侵袭、转移、血管生成、干细胞特性及耐药性等方面发挥调节作用。本文综述了lncRNA SNHG基因家族在HCC中的发生机制及预后价值，以期为该领域的基础和临床研究提供新思路。
- RNA, 长链非编码 /
- 癌，肝细胞 /
- 作用机制 /
- 预后
Abstract: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is one of the leading causes of cancer-related deaths. Despite the in-depth research on HCC at present, the underlying molecular mechanisms are still unclear. Recent studies have revealed that long non-coding RNAs (lncRNAs) play an important role in the development and progression of HCC, and long non-coding RNA small nucleolar RNA host genes (lncRNA SNHGs) show abnormal expression in HCC and play regulatory roles in the proliferation, invasion, metastasis, angiogenesis, stemness, and drug resistance of tumor cells. This article reviews the mechanism and prognostic value of the lncRNA SNHG family in HCC, so as to provide new ideas for basic and clinical research in this field.
- RNA, Long Noncodings /
- Carcinoma, Hepatocellular /
- Mechanism /
- Prognosis

HTML全文

图 1 SNHG在HCC中的机制示意图

Figure 1. Diagram of the mechanism of SNHG in HCC

下载: 全尺寸图片幻灯片

参考文献(40)

[1]	WEI L, WANG X, LV L, et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1): 147. DOI: 10.1186/s12943-019-1086-z.
[2]	LI Y, WANG X, CHEN S, et al. Long non-coding RNA small nucleolar RNA host genes: functions and mechanisms in hepatocellular carcinoma[J]. Mol Biol Rep, 2022, 49(3): 2455-2464. DOI: 10.1007/s11033-021-07018-0.
[3]	JIANG Y, HAN QJ, ZHANG J. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy[J]. World J Gastroenterol, 2019, 25(25): 3151-3167. DOI: 10.3748/wjg.v25.i25.3151.
[4]	WANG PS, WANG Z, YANG C. Dysregulations of long non-coding RNAs - The emerging "lnc" in environmental carcinogenesis[J]. Semin Cancer Biol, 2021, 76: 163-172. DOI: 10.1016/j.semcancer.2021.03.029.
[5]	SAEINASAB M, ATLASI Y, M MATIN M. Functional role of lncRNAs in gastrointestinal malignancies: the peculiar case of small nucleolar RNA host gene family[J]. FEBS J, 2022. DOI: 10.1111/febs.16668.[Online ahead of print]
[6]	LI J, YU H, YAO J, et al. Integrative analysis and experimental validation indicated that SNHG17 is a prognostic marker in prostate cancer and a modulator of the tumor microenvironment via a competitive endogenous RNA regulatory network[J]. Oxid Med Cell Longev, 2022, 2022: 1747604. DOI: 10.1155/2022/1747604.
[7]	LI B, LI A, YOU Z, et al. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma[J]. Cell Death Dis, 2020, 11(10): 823. DOI: 10.1038/s41419-020-03031-6.
[8]	ZHANG WY, ZHAN HL, LI MK, et al. Long noncoding RNA Gas5 induces cell apoptosis and inhibits tumor growth via activating the CHOP-dependent endoplasmic reticulum stress pathway in human hepatoblastoma HepG2 cells[J]. J Cell Biochem, 2022, 123(2): 231-247. DOI: 10.1002/jcb.30159.
[9]	WU J, LIU L, JIN H, et al. LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma[J]. Onco Targets Ther, 2019, 12: 6623-6638. DOI: 10.2147/OTT.S196630.
[10]	YANG X, SUN L, WANG L, et al. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4[J]. Biomed Pharmacother, 2019, 118: 109386. DOI: 10.1016/j.biopha.2019.109386.
[11]	DONG J, TENG F, GUO W, et al. lncRNA SNHG8 promotes the tumorigenesis and metastasis by sponging miR-149-5p and predicts tumor recurrence in hepatocellular carcinoma[J]. Cell Physiol Biochem, 2018, 51(5): 2262-2274. DOI: 10.1159/000495871.
[12]	YE S, NI Y. lncRNA SNHG9 promotes cell proliferation, migration, and invasion in human hepatocellular carcinoma cells by increasing GSTP1 methylation, as revealed by CRISPR-dCas9[J]. Front Mol Biosci, 2021, 8: 649976. DOI: 10.3389/fmolb.2021.649976.
[13]	LAN T, YUAN K, YAN X, et al. LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop[J]. Cancer Res, 2019, 79(13): 3220-3234. DOI: 10.1158/0008-5472.CAN-18-4044.
[14]	LAN T, MA W, HONG Z, et al. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2017, 36(1): 11. DOI: 10.1186/s13046-016-0486-9.
[15]	CHEN PP, ZHANG ZS, WU JC, et al. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p[J]. Cell Signal, 2021, 84: 109992. DOI: 10.1016/j.cellsig.2021.109992.
[16]	XU X, SONG F, JIANG X, et al. Long non-coding RNA SNHG14 contributes to the development of hepatocellular carcinoma via sponging miR-217[J]. Onco Targets Ther, 2020, 13: 4865-4876. DOI: 10.2147/OTT.S244530.
[17]	LI S, PENG F, NING Y, et al. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma[J]. J Cell Biochem, 2020, 121(3): 2543-2558. DOI: 10.1002/jcb.29477.
[18]	MA T, ZHOU X, WEI H, et al. Long non-coding RNA SNHG17 upregulates RFX1 by sponging miR-3180-3p and promotes cellular function in hepatocellular carcinoma[J]. Front Genet, 2020, 11: 607636. DOI: 10.3389/fgene.2020.607636.
[19]	TU W, YANG Y, SONG Y, et al. Hepatitis B virus x protein accelerated the proliferation of hepatocellular carcinoma cell through lncRNA SNHG20/PTEN pathway[J]. J Biochem, 2019, 165(5): 423-431. DOI: 10.1093/jb/mvy120.
[20]	SHIGETA K, DATTA M, HATO T, et al. Dual programmed death receptor-1 and vascular endothelial growth factor receptor-2 blockade promotes vascular normalization and enhances antitumor immune responses in hepatocellular carcinoma[J]. Hepatology, 2020, 71(4): 1247-1261. DOI: 10.1002/hep.30889.
[21]	ZHANG H, XU HB, KURBAN E, et al. LncRNA SNHG14 promotes hepatocellular carcinoma progression via H3K27 acetylation activated PABPC1 by PTEN signaling[J]. Cell Death Dis, 2020, 11(8): 646. DOI: 10.1038/s41419-020-02808-z.
[22]	LUO Y, LIN J, ZHANG J, et al. LncRNA SNHG17 contributes to proliferation, migration, and poor prognosis of hepatocellular carcinoma[J]. Can J Gastroenterol Hepatol, 2021, 2021: 9990338. DOI: 10.1155/2021/9990338.
[23]	ZHAN T, GAO X, WANG G, et al. Construction of novel lncRNA-miRNA-mRNA network associated with recurrence and identification of immune-related potential regulatory axis in hepatocellular carcinoma[J]. Front Oncol, 2021, 11: 626663. DOI: 10.3389/fonc.2021.626663.
[24]	FANG P, XIANG L, CHEN W, et al. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3[J]. Innate Immun, 2019, 25(2): 99-109. DOI: 10.1177/1753425919827632.
[25]	WANG G, XU J, ZHAO J, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice[J]. Nat Commun, 2020, 11(1): 220. DOI: 10.1038/s41467-019-14046-9.
[26]	LI Y, HU J, GUO D, et al. LncRNA SNHG5 promotes the proliferation and cancer stem cell-like properties of HCC by regulating UPF1 and Wnt-signaling pathway[J]. Cancer Gene Ther, 2022, 29(10): 1373-1383. DOI: 10.1038/s41417-022-00456-3.
[27]	GAO S, XU X, WANG Y, et al. Diagnostic utility of plasma lncRNA small nucleolar RNA host gene 1 in patients with hepatocellular carcinoma[J]. Mol Med Rep, 2018, 18(3): 3305-3313. DOI: 10.3892/mmr.2018.9336.
[28]	SHUAI Y, MA Z, LU J, et al. LncRNA SNHG15: A new budding star in human cancers[J]. Cell Prolif, 2020, 53(1): e12716. DOI: 10.1111/cpr.12716.
[29]	ZHANG Z, WANG F, ZHANG J, et al. An m6A-related lncRNA signature predicts the prognosis of hepatocellular carcinoma[J]. Front Pharmacol, 2022, 13: 854851. DOI: 10.3389/fphar.2022.854851.
[30]	ZHU Q, YANG H, CHENG P, et al. Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma[J]. Biofactors, 2019, 45(2): 244-252. DOI: 10.1002/biof.1478.
[31]	HUANG W, HUANG F, LEI Z, et al. LncRNA SNHG11 promotes proliferation, migration, apoptosis, and autophagy by regulating hsa-miR-184/AGO2 in HCC[J]. Onco Targets Ther, 2020, 13: 413-421. DOI: 10.2147/OTT.S237161.
[32]	GUO D, LI Y, CHEN Y, et al. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway[J]. Cell Prolif, 2019, 52(4): e12628. DOI: 10.1111/cpr.12628.
[33]	LIU Y, CHEN L, YUAN H, et al. LncRNA DANCR promotes sorafenib resistance via activation of IL-6/STAT3 signaling in hepatocellular carcinoma cells[J]. Onco Targets Ther, 2020, 13: 1145-1157. DOI: 10.2147/OTT.S229957.
[34]	LIU XF, THIN KZ, MING XL, et al. Small nucleolar RNA host gene 18 acts as a tumor suppressor and a diagnostic indicator in hepatocellular carcinoma[J]. Technol Cancer Res Treat, 2018, 17: 1533033818794494. DOI: 10.1177/1533033818794494.
[35]	SANGRO B, SAROBE P, HERVÁS-STUBBS S, et al. Advances in immunotherapy for hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(8): 525-543. DOI: 10.1038/s41575-021-00438-0.
[36]	LI W, DONG X, HE C, et al. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells[J]. J Exp Clin Cancer Res, 2019, 38(1): 183. DOI: 10.1186/s13046-019-1177-0.
[37]	WANG C, KE S, LI M, et al. Downregulation of LncRNA GAS5 promotes liver cancer proliferation and drug resistance by decreasing PTEN expression[J]. Mol Genet Genomics, 2020, 295(1): 251-260. DOI: 10.1007/s00438-019-01620-5.
[38]	ZHAO P, CUI X, ZHAO L, et al. Overexpression of growth-arrest-specific transcript 5 improved cisplatin sensitivity in hepatocellular carcinoma through sponging miR-222[J]. DNA Cell Biol, 2020, 39(4): 724-732. DOI: 10.1089/dna.2019.5282.
[39]	ZHANG PF, WANG F, WU J, et al. LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma[J]. J Cell Physiol, 2019, 234(3): 2788-2794. DOI: 10.1002/jcp.27095.
[40]	YE J, ZHANG R, DU X, et al. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p[J]. Onco Targets Ther, 2019, 12: 415-422. DOI: 10.2147/OTT.S175176.